Estrogen and insulin-like growth factor-I (IGF-I) independently down-regulate critical repressors of breast cancer growth-Reference-Cited by-同舟云学术

Estrogen and insulin-like growth factor-I (IGF-I) independently down-regulate critical repressors of breast cancer growth

Published:2011-05-04 Issue:1 Volume:132 Page:61-73
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Casa Angelo J.,Potter Adam S.,Malik Simeen,Lazard ZaWaunyka,Kuiatse Isere,Kim Hee-Tae,Tsimelzon Anna,Creighton Chad J.,Hilsenbeck Susan G.,Brown Powell H.,Oesterreich Steffi,Lee Adrian V.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-011-1540-0.pdf

Reference41 articles.

1. Hall JM, Couse JF, Korach KS (2001) The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 276:36869–36872

2. Casa AJ, Dearth RK, Litzenburger BC, Lee AV, Cui X (2008) The type I insulin-like growth factor receptor pathway: a key player in cancer therapeutic resistance. Front Biosci 13:3273–3287

3. Sachdev D, Yee D (2001) The IGF system and breast cancer. Endocr Relat Cancer 8:197–209

4. Richards RG, DiAugustine RP, Petrusz P, Clark GC, Sebastian J (1996) Estradiol stimulates tyrosine phosphorylation of the insulin-like growth factor-1 receptor and insulin receptor substrate-1 in the uterus. Proc Natl Acad Sci USA 93:12002–12007

5. Richards RG, Walker MP, Sebastian J, DiAugustine RP (1998) Insulin-like growth factor-1 (IGF-1) receptor-insulin receptor substrate complexes in the uterus. Altered signaling response to estradiol in the IGF-1(m/m) mouse. J Biol Chem 273:11962–11969

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Newly synthesized chitosan nanoparticles loaded with caffeine/moringa leaf extracts Halt Her2, BRCA1, and BRCA2 expressions;Scientific Reports;2024-08-05

2. Triglyceride-Glucose Index: A Candidate Prognostic Marker in HR-Positive/HER2-Negative Metastatic Breast Cancer Patients Treated With CDK4/6 Inhibitors;Clinical Breast Cancer;2024-08

3. Glucose-dependent effect of insulin receptor isoforms on tamoxifen antitumor activity in estrogen receptor-positive breast cancer cells;Frontiers in Endocrinology;2023-06-09

4. Comparative Analysis of Transcriptomic Changes including mRNA and microRNA Expression Induced by the Xenoestrogens Zearalenone and Bisphenol A in Human Ovarian Cells;Toxins;2023-02-09

5. Can We Mitigate Coronary Heart Disease Risk in Patients with Cancer?;Current Atherosclerosis Reports;2022-05-28